Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Furiex Confirms Takeda's Resubmissions Of Alogliptin NDAs To FDA
Furiex Confirms Takeda's Resubmissions Of Alogliptin NDAs To FDA
Furiex Confirms Takeda's Resubmissions Of Alogliptin NDAs To FDA
Submitted by
admin
on July 29, 2012 - 1:03pm
Source:
NASDAQ
News Tags:
Furiex Pharmaceuticals
Takeda
alogliptin
diabetes
type 2 diabetes
Headline:
Furiex Confirms Takeda's Resubmissions Of Alogliptin NDAs To FDA
Do Not Allow Advertisers to Use My Personal information
